|
|
|
Company
Name |
Short
Summary |
| aaiPharma |
aaiPharma
is involved in the acquisition, improvement, and
marketing of branded medicines primarily in pain
management and critical care. |
| Adamas Pharmaceuticals |
Adamas Pharmaceuticals is focused on developing small molecule therapeutics to treat neurological and infectious diseases, including influenza A. |
| AllCells |
AllCells is focused on providing primary cells, RNA, and cDNA from normal and disease-state tissues for use in research. |
| Angelica Therapeutics |
Angelica Therapeutics is focused on the research and development of cancer therapeutics based on proprietary fusion toxins. |
| Bayer |
Bayer develops and markets various
drugs and chemicals. |
| Bionovo |
Bionovo is focused on the discovery, research and development of drugs derived from botanical sources which have novel mechanisms of action with a focus on women's health and cancer. |
| Crystal Bioscience |
Crystal Bioscience is focused on providing monoclonal antibody research and development services for pharmaceutical and biotech companies. |
| NovaBay Pharmaceuticals |
NovaBay Pharmaceuticals is focused on developing anti-infective compounds for the treatment and prevention of antibiotic-resistant infections. |
| Peplin |
Peplin is focused on advancing and commercializing dermatology products. |
| Tethys Bioscience |
Tethys Bioscience is focused on biomarkers to predict, diagnose, and direct treatment of chronic metabolic diseases such as diabetes. |
| Zogenix |
Zogenix is focused on the development and commercialization of products for the treatment of pain and central nervous system disorders. |
